Last updated on January 2020

Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or S zary Syndrome (SS)

Brief description of study

The purpose of this study is to determine whether resminostat will be able to delay or prevent worsening of disease in patients with advanced stage mycosis fungoides or Szary Syndrome that have recently achieved disease control with previous systemic therapy.

Clinical Study Identifier: NCT02953301

Find a site near you

Start Over

CHU Estaing

Clermont-Ferrand, France
  Connect »

Kantonsspital St. Gallen

St. Gallen, Switzerland
  Connect »

University Hospital

Birmingham, United Kingdom
  Connect »

Christie Hospital

Manchester, United Kingdom
  Connect »